CN
CN EN
R&D Fields
Adhering to the innovation-driven development strategy, and following the idea of "people-oriented innovation", Kexing Biopharm has been focused on major biopharmaceutical business and devoted to the development of recombinant protein therapeutics, while seeking wider applications of cutting-edge biotechnology. It is committed to developing next-generation innovative biological products and biosimilar products for the treatment of diseases that have significant impacts on human life and health, including antiviral, hematology, oncology and immunology, and degenerative diseases. Through innovative research and development, Kexing Biopharm provides patients with high-quality products for safe, effective, and precise treatment to meet the unmet clinical needs that need to be addressed urgently.

R&D Fields